Alaa Jammoul

Alaa Jammoul

Auto-generated profile, based on publicly available information

Alaa Jammoul


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
BABarbara Azzimonti
Barbara Azzimonti
MLMoreno Lelli
Moreno Lelli
AJAlaa Jammoul
Alaa Jammoul
CAChiara Airoldi
Chiara Airoldi
Chiara Maria Teresa BoggioChiara Maria Teresa Boggio
Chiara Maria Teresa Boggio
AVAlessia Vignoli
Alessia Vignoli
Atopic dermatitis (AD) is a chronic inflammatory skin disease often requiring systemic biological therapies, such as the IL-4/IL-13 inhibitor Dupilumab, for long-term disease control. While Dupilumab is highly effective in restoring the skin barrier and reducing clinical severity, systemic complications may occur. We report a 62-year-old female with severe AD longitudinally monitored during Dupilumab treatment at baseline (T0), week 4 (T4), week 8 (T8), and week 16 (T16). Clinical assessments were performed at all visits, while microbiological, cytokine, metagenomic, and metabolomic analyses were conducted at T0, T8, and T16. The patient showed rapid clinical improvement at T4, followed by an abrupt transient worsening associated with an intercurrent S. aureus sepsis, and sustained improvement by T16, with EASI decreasing from 50.4 to 20. Despite the systemic inflammatory surge, no cutaneous relapse was documented. Multi-omics profiling highlighted a distinct immunological decoupling: while skin S. aureus load and type 2 inflammatory markers (IL-13, IL-31) progressively declined, a sharp surge in systemic pro-inflammatory cytokines (TNF-alpha) was observed at week 16, temporally associated with the septic episode. This case illustrates how longitudinal multi-omics profiling may uncover clinically silent systemic immune alterations that are not captured by conventional disease activity scores.